[1]
“Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with Rituximab-CHOP in Ibadan, Nigeria: a Case Report”., Mediterr J Hematol Infect Dis, vol. 3, no. 1, p. e2011008, Mar. 2011, doi: 10.4084/mjhid.2011.008.